Tirzepatide vs Other Compounds
How Tirzepatide compares to related peptides and compounds in research contexts.
Tirzepatide vs Retatrutide: Tirzepatide is a dual GLP-1/GIP agonist, while retatrutide adds glucagon receptor activation. Researchers compare both to study the incremental metabolic effects of triple vs. dual receptor targeting.
Tirzepatide vs Semaglutide: Semaglutide is a selective GLP-1R agonist. Tirzepatide's dual receptor profile produces enhanced metabolic effects through GIPR co-activation, making it valuable for studying receptor synergy.
More about Tirzepatide
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption or clinical use. Always follow applicable laws and regulations.